Subscribe to The Pharma Letter

Join our growing number of subscribers to The Pharma Letter where we give you insightful opinion and analysis on the pharmaceutical and biotechnology industries.

A subscription gives you unlimited access to The Pharma Letter website for a whole year all for only £60 per month!

Click here to subscribe

Subscribe Now to The Pharma Letter

..and get all this for just £60 per month:

  • No-limits access to our new website with up-to-the minute news
  • Online discussion forums and Q&A section
  • RSS news feeds that you can add to your favourite reader, or website
  • Daily news email alert, with the breaking stories
  • Much, much more!

Click here to subscribe

"Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. Its part of the key information for keeping me informed"
Nigel Brooksby, Chairman, Sanofi aventis UK Ltd

More testimonials

'I use the Pharma Letter to keep abreast of regulatory issues, I trust it's quality'

'We are keen to ensure that our clients are well represented in the Pharma Letter as it has great context and we know they read it'

'It has the right information, in the right format at the right time'

'A news source with a truly global perspective; from Sydney to San Francisco, our people read it'

GSK, Novartis, Pfizer, Merck, Astra Zeneca, Nycomed, Novo Nordisk Nycomed Novartis AstraZeneca Pfizer GSK Merck Novo Nordisk


 

Want to talk to someone before signing up?

Give us a call on +44 (0) 208 780 6363 from 9am to 6pm GMT, Monday to Friday
or email us: enquiries "at" thepharmaletter.com




Start your Subscription to The Pharma Letter today Subscribe Now